Suggestions
Walter Harvey Crompton
Advocate and investor for accessible, safe, and reliable interventions to boost lifelong neuro-physical health, with a current specialization in simple pre-adult interventions
Walter Harvey Crompton is a versatile professional with a multi-faceted background as an entrepreneur, investor, engineer, and activist, dedicated to pioneering medical advancements, particularly in the field of geroscience. With a strong emphasis on innovative therapies, he has a proven track record of managing compliance, risk, supplier, and production challenges.
Walter holds a Master's degree in Electrical Engineering (MSEE) with a specialization in Power Engineering from the State University of New York at Buffalo, showcasing his academic prowess in his area of expertise.
Throughout his career, Walter has held key positions in various organizations, including Director of Special Projects at Yuvan Research, Inc., Program Manager at DataBETA Research Study, Founder and CTO at VivaFina, along with contributing as a Volunteer/Activist at SENS Research Foundation. His vast professional journey also includes roles in quality assurance, compliance engineering, and program management in renowned companies like Johnson & Johnson, Harmontronics Automation Technology, and Boston Scientific, to name a few.
Walter's extensive experience encompasses a wide range of responsibilities, from teaching and entrepreneurship to quality and compliance engineering, reflecting his diverse skill set and proficiency in the medical and technology sectors. With a rich history of managing quality systems, product improvement initiatives, and strategic operations, he has established himself as a seasoned professional with a deep commitment to driving impactful change in the healthcare industry.
As a passionate advocate for cutting-edge medical solutions and proactive approaches to healthcare challenges, Walter Harvey Crompton continues to make significant contributions to the field, leveraging his expertise, insights, and leadership to push the boundaries of innovation in geroscience and beyond.